| Title |
Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy
|
|---|---|
| Published in |
Canadian Medical Association Journal, October 2010
|
| DOI | 10.1503/cmaj.091298 |
| Pubmed ID | |
| Authors |
Xinmei Kang, Qingyuan Zhang, Shuhuai Wang, Xu Huang, Shi Jin |
| Abstract |
The intake of soy isoflavones among women with breast cancer has become a public health concern, because these compounds have weak estrogenic effects. There is little clinical evidence about their safety for patients with breast cancer who are receiving adjuvant endocrine therapy. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 1% |
| United States | 2 | 1% |
| United Kingdom | 1 | <1% |
| Unknown | 145 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 31 | 21% |
| Researcher | 23 | 15% |
| Student > Bachelor | 19 | 13% |
| Other | 11 | 7% |
| Student > Ph. D. Student | 8 | 5% |
| Other | 20 | 13% |
| Unknown | 38 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 26% |
| Agricultural and Biological Sciences | 22 | 15% |
| Nursing and Health Professions | 13 | 9% |
| Biochemistry, Genetics and Molecular Biology | 7 | 5% |
| Social Sciences | 5 | 3% |
| Other | 22 | 15% |
| Unknown | 42 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 82. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2024.
All research outputs
#528,279
of 25,654,566 outputs
Outputs from Canadian Medical Association Journal
#892
of 9,521 outputs
Outputs of similar age
#1,390
of 108,377 outputs
Outputs of similar age from Canadian Medical Association Journal
#5
of 62 outputs
Altmetric has tracked 25,654,566 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,521 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,377 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.